ABVC BioPharma, Inc. (ABVC)

NASDAQ: ABVC · IEX Real-Time Price · USD

1.16

-0.09 (-7.20%)

At close: Dec 29, 2023, 4:00 PM

1.19

+0.03 (2.59%)

After-hours: Dec 29, 2023, 7:38 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Revenue	0.97	0.36	0.48	0.7
Revenue Growth (YoY)	172.57%	-26.34%	-31.16%	-
Cost of Revenue	0.29	0.01	0.02	0.02
Gross Profit	0.68	0.35	0.46	0.68
Selling, General & Admin	6.07	5.75	4.27	3.07
Research & Development	2.69	1	0.55	1.05
Other Operating Expenses	7.04	5.31	4.15	0.02
Operating Expenses	15.8	12.06	8.97	4.14
Operating Income	-15.11	-11.71	-8.51	-3.46
Interest Expense / Income	0.29	0.23	0.41	0.48
Other Expense / Income	0.22	0.08	1.1	-0.22
Pretax Income	-15.63	-12.01	-10.01	-3.72
Income Tax	0.8	0.83	-0.22	-0.08
Net Income	-16.42	-12.84	-9.79	-3.64
Shares Outstanding (Basic)	3	3	2	2
Shares Outstanding (Diluted)	3	3	2	2
Shares Change	26.39%	27.07%	12.67%	-
EPS (Basic)	-5.20	-5.10	-5.00	-2.10
EPS (Diluted)	-5.20	-5.10	-5.00	-2.10
Free Cash Flow	-7.52	-7.62	-4.56	-3.13
Free Cash Flow Per Share	-2.37	-3.04	-2.31	-1.79
Gross Margin	70.47%	98.57%	96.13%	97.13%
Operating Margin	-1558.54%	-3290.07%	-1760.87%	-492.90%
Profit Margin	-1693.50%	-3608.47%	-2026.97%	-518.98%
Free Cash Flow Margin	-775.23%	-2140.33%	-944.82%	-446.69%
EBITDA	-15.31	-11.77	-9.57	-3.18
EBITDA Margin	-1578.47%	-3309.36%	-1981.05%	-453.42%
Depreciation & Amortization	0.02	0.01	0.04	0.06
EBIT	-15.33	-11.79	-9.61	-3.24
EBIT Margin	-1580.92%	-3312.73%	-1988.73%	-461.27%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).